Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Exalenz Bioscience Ltd Announces Resignation of Chief Executive Officer, Mr. Steven Eitan


Wednesday, 21 Nov 2012 07:00pm EST 

Exalenz Bioscience Ltd announced that its Chief Executive Officer, Mr. Steven Eitan, will resign from the Company, effective from March 31, 2013. 

Company Quote

11.5
0.5 +4.55%
28 Aug 2014